InnoCan Pharma Corporation
INNO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.21% | 13.98% | 27.10% | -0.97% | -2.54% |
| Total Receivables | 7.81% | -32.72% | 102.43% | -21.98% | 72.61% |
| Inventory | -6.03% | -11.85% | -10.94% | -3.18% | 28.75% |
| Prepaid Expenses | 14.89% | -32.86% | 4.48% | -64.17% | -9.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 54.82% | 27.54% | 7.76% | 82.50% | -14.29% |
| Total Current Assets | 0.80% | 2.12% | 17.09% | -3.48% | 10.27% |
|
|
|||||
| Total Current Assets | 0.80% | 2.12% | 17.09% | -3.48% | 10.27% |
| Net Property, Plant & Equipment | -7.00% | -6.54% | -5.31% | -4.24% | -3.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 0.72% | 2.03% | 16.81% | -3.49% | 10.08% |
|
|
|||||
| Total Accounts Payable | -81.55% | 30.90% | -3.78% | 40.15% | -66.07% |
| Total Accrued Expenses | 0.00% | -15.99% | 49.16% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -57.14% | -30.00% | -- | -- |
| Total Finance Division Other Current Liabilities | 9.49% | 22.56% | 10.48% | -37.92% | 10.47% |
| Total Other Current Liabilities | 9.49% | 22.56% | 10.48% | -37.92% | 10.47% |
| Total Current Liabilities | 0.27% | 12.45% | 17.38% | -15.64% | -0.67% |
|
|
|||||
| Total Current Liabilities | 0.27% | 12.45% | 17.38% | -15.64% | -0.67% |
| Long-Term Debt | 9.25% | 7.07% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -75.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.15% | 10.66% | 75.56% | -15.67% | -0.79% |
|
|
|||||
| Common Stock & APIC | 3.96% | 0.29% | 0.24% | 0.32% | 1.57% |
| Retained Earnings | -5.40% | -1.66% | -1.67% | -0.33% | -0.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -8.37% | -10.13% | -9.43% | 0.29% | 6.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.37% | -10.13% | -9.43% | 0.29% | 6.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 11.88% | 12.45% | 19.03% | 3.69% | 47.24% |
| Total Equity | -0.85% | -2.89% | -1.91% | 1.17% | 14.90% |
|
|
|||||